DDD 3D Systems Corporation

3D Systems Announces Chief Financial Officer Transition

3D Systems Announces Chief Financial Officer Transition

  • 3D Systems’ Executive Vice President, Phyllis Nordstrom to Serve as Interim Chief Financial Officer

ROCK HILL, S.C., Aug. 20, 2025 (GLOBE NEWSWIRE) -- Today, (NYSE: DDD) announced that Jeffrey D. Creech is stepping down as the company’s Chief Financial Officer, effective August 29, 2025, to accept a new career opportunity. Phyllis Nordstrom, 3D Systems’ Executive Vice President, Chief Administrative Officer, has been appointed Interim CFO, effective August 29, 2025.

“I want to thank Jeff for his dedication and leadership as we have executed on key strategic initiatives such as our manufacturing insourcing and cost improvement plans that are driving improvements in operating performance,” said Dr. Jeffrey Graves, president and CEO of 3D Systems. “I wish Jeff continued success as he moves to this next chapter in his career. I am very pleased that Phyllis will assume this role. She is a proven leader with a highly successful track record at 3D Systems in driving organizational alignment, cross-business process improvements, and strengthening of our risk management and control environment. These capabilities, combined with her strong financial background, position her well for taking on these responsibilities, and I look forward to the meaningful impact she will have on the company’s future success.”

Joining in 2021, Ms. Nordstrom currently serves as Executive Vice President, Chief People Officer, and Chief Administrative Officer for 3D Systems, responsible for leading the Company’s global human resources strategy, internal audit and compliance programs, and overseeing information technology and cyber-security for the Company. Over the course of her career, Ms. Nordstrom has served in numerous roles within finance, accounting and risk management, including leadership roles at MTS Systems Corporation, PricewaterhouseCoopers, Target, and U.S. Bank. She also holds a Bachelor of Science degree in Accounting from Louisiana State University.

About 3D Systems

For nearly 40 years, Chuck Hull’s curiosity and desire to improve the way products were designed and manufactured gave birth to 3D printing, 3D Systems, and the additive manufacturing industry. Since then, that same spark continues to ignite the 3D Systems team as we work side-by-side with our customers to change the way industries innovate. As a full-service solutions partner, we deliver industry-leading 3D printing technologies, materials and software to high-value markets such as medical and dental; aerospace, space and defense; transportation and motorsports; AI infrastructure; and durable goods. Each application-specific solution is powered by the expertise and passion of our employees who endeavor to achieve our shared goal of Transforming Manufacturing for a Better Future. More information on the company is available at .

Investor Contact:

Media Contact:

A photo accompanying this announcement is available at



EN
20/08/2025

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on 3D Systems Corporation

 PRESS RELEASE

3D Systems Announces Chief Financial Officer Transition

3D Systems Announces Chief Financial Officer Transition 3D Systems’ Executive Vice President, Phyllis Nordstrom to Serve as Interim Chief Financial Officer ROCK HILL, S.C., Aug. 20, 2025 (GLOBE NEWSWIRE) -- Today, (NYSE: DDD) announced that Jeffrey D. Creech is stepping down as the company’s Chief Financial Officer, effective August 29, 2025, to accept a new career opportunity. Phyllis Nordstrom, 3D Systems’ Executive Vice President, Chief Administrative Officer, has been appointed Interim CFO, effective August 29, 2025. “I want to thank Jeff for his dedication and leadership as we hav...

 PRESS RELEASE

3D Systems Reports Second Quarter 2025 Financial Results

3D Systems Reports Second Quarter 2025 Financial Results ROCK HILL, S.C., Aug. 11, 2025 (GLOBE NEWSWIRE) --  (NYSE:DDD) announced today its financial results for the second quarter ended June 30, 2025. Revenue of $95 million led by double-digit growth in Medical Technology and Aerospace & Defense marketsRegenerative Medicine partnership with United Therapeutics targeted on manufacture of human lungs reached a new printing milestone resulting in a $2 million award in the quarterCost reduction and efficiency programs resulted in over $20 million of savings in operating expenses in Q2Compan...

 PRESS RELEASE

3D Systems Announces Date of Second Quarter 2025 Financial Results

3D Systems Announces Date of Second Quarter 2025 Financial Results ROCK HILL, S.C., Aug. 04, 2025 (GLOBE NEWSWIRE) -- (NYSE:DDD) announced today it will release its financial results for the second quarter 2025 after the U.S. stock markets close on Monday, August 11, 2025. The company will hold a conference call and simultaneous webcast to discuss these financial results on Tuesday, August 12, 2025 at 8:30 a.m. Eastern Time. Second Quarter 2025 Financial Results Conference Call Date: Tuesday, August 12, 2025 Time: 8:30 a.m. Eastern Time Listen via webcast: Participate via telephon...

 PRESS RELEASE

3D Systems Announces Major Milestone in Digital Dentistry with Full Co...

3D Systems Announces Major Milestone in Digital Dentistry with Full Commercial Release of New FDA-cleared Denture Solution Company’s technology redefines dental prosthetics with revolutionary single-piece, multi-material dentures delivering distinctive combination of exquisite aesthetics, comfort and outstanding resistance to breakage for enhanced patient experienceNextDent® Jetted Denture Solution validated with strong endorsements from beta customers highlighting effortless usability, unmatched material properties and ground-breaking efficiency improvements of up to 300%Commercial availab...

 PRESS RELEASE

3D Systems Advances Regenerative Medical Solutions for First-of-its-Ki...

3D Systems Advances Regenerative Medical Solutions for First-of-its-Kind Peripheral Nerve Repair Collaboration with French MedTech company, TISSIUM, has resulted in FDA approval for unique 3D-printed polymeric solution for repair of peripheral nerve damage3D Systems’ bioprinting system enabled production of a 3D-printed bioabsorbable medical device leveraging TISSIUM’s proprietary biomorphic programable polymers—a major industry milestone that sets new standard for high resolution elastomeric 3D-printed medical implantsBuilds on 3D Systems’ pioneering work to develop additive manufacturing ...

ResearchPool Subscriptions

Get the most out of your insights

Get in touch